Search Results - "Natsuki, Yuka"

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    New-onset Type 1 Diabetes after COVID-19 mRNA Vaccination by Yano, Masahiro, Morioka, Tomoaki, Natsuki, Yuka, Sasaki, Keyaki, Kakutani, Yoshinori, Ochi, Akinobu, Yamazaki, Yuko, Shoji, Tetsuo, Emoto, Masanori

    Published in Internal Medicine (15-04-2022)
    “…During the ongoing coronavirus disease 2019 (COVID-19) pandemic, it is critical to ensure the safety of COVID-19 vaccines. We herein report a 51-year-old…”
    Get full text
    Journal Article
  2. 2

    New‐onset fulminant type 1 diabetes after severe acute respiratory syndrome coronavirus 2 vaccination: A case report by Sasaki, Keyaki, Morioka, Tomoaki, Okada, Natsumi, Natsuki, Yuka, Kakutani, Yoshinori, Ochi, Akinobu, Yamazaki, Yuko, Shoji, Tetsuo, Ohmura, Takashi, Emoto, Masanori

    Published in Journal of diabetes investigation (01-07-2022)
    “…Fulminant type 1 diabetes is characterized by a rapid progression of insulin deficiency triggered by viral infection. Here, we report a case of a 45‐year‐old…”
    Get full text
    Journal Article
  3. 3

    Seronegative Full-house Nephropathy with Crohn's Disease by Uedono, Hideki, Tsuda, Akihiro, Ueno, Noriko, Natsuki, Yuka, Nakaya, Rino, Nishide, Kozo, Machiba, Yuri, Fujimoto, Kenta, Nakatani, Shinya, Mori, Katsuhito, Emoto, Masanori

    Published in Internal Medicine (01-12-2022)
    “…Systemic lupus erythematosus (SLE) is a chronic autoimmune inflammatory disease. Lupus nephritis (LN) is a major risk factor for mortality in SLE, and…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Serum Fibroblast Growth Factor 23 Levels are Associated with Vascular Smooth Muscle Dysfunction in Type 2 Diabetes by Natsuki, Yuka, Morioka, Tomoaki, Kakutani, Yoshinori, Yamazaki, Yuko, Ochi, Akinobu, Kurajoh, Masafumi, Mori, Katsuhito, Imanishi, Yasuo, Shoji, Tetsuo, Inaba, Masaaki, Emoto, Masanori

    Published in Journal of Atherosclerosis and Thrombosis (01-12-2023)
    “…Aim: Increased level of serum fibroblast growth factor 23 (FGF23) is a hallmark of abnormal phosphate metabolism in patients with chronic kidney disease (CKD)…”
    Get full text
    Journal Article
  7. 7

    440-P: Influence of Sex on the Association between Vascular Endothelial Dysfunction and Plasma Leptin Levels in People with Type 2 Diabetes by Morioka, Tomoaki, Natsuki, Yuka, Kakutani, Yoshinori, Yamazaki, Yuko, Kurajoh, Masafumi, Mori, Katsuhito, Shoji, Tetsuo, Emoto, Masanori

    Published in Diabetes (New York, N.Y.) (01-06-2024)
    “…Evidence from basic studies indicates that leptin, a key hormone in the regulation of food intake and energy expenditure, induces endothelium-dependent…”
    Get full text
    Journal Article
  8. 8

    A Case of New-onset Type 1 Diabetes after Covid-19 mRNA Vaccination by Yano, Masahiro, Morioka, Tomoaki, Natsuki, Yuka, Sasaki, Keyaki, Kakutani, Yoshinori, Ochi, Akinobu, Yamazaki, Yuko, Shoji, Tetsuo, Emoto, Masanori

    Published in Internal Medicine (2022)
    “…During the ongoing coronavirus disease 2019 (Covid-19) pandemic, it is critical to ensure the safety of Covid-19 vaccines. We herein report a 51-year-old…”
    Get full text
    Journal Article
  9. 9

    Serum Fibroblast Growth Factor 23 Levels are Associated with Vascular Smooth Muscle Dysfunction in Type 2 Diabetes by Natsuki, Yuka, Morioka, Tomoaki, Kakutani, Yoshinori, Yamazaki, Yuko, Ochi, Akinobu, Kurajoh, Masafumi, Mori, Katsuhito, Imanishi, Yasuo, Shoji, Tetsuo, Inaba, Masaaki, Emoto, Masanori

    “…Aim: Increased level of serum fibroblast growth factor 23 (FGF23) is a hallmark of abnormal phosphate metabolism in patients with chronic kidney disease (CKD)…”
    Get full text
    Journal Article
  10. 10
  11. 11

    A Case of Seronegative Full-house Nephropathy with Crohn's Disease by Uedono, Hideki, Tsuda, Akihiro, Ueno, Noriko, Natsuki, Yuka, Nakaya, Rino, Nishide, Kozo, Machiba, Yuri, Fujimoto, Kenta, Nakatani, Shinya, Mori, Katsuhito, Emoto, Masanori

    Published in Internal Medicine (2022)
    “…Systemic lupus erythematosus (SLE) is a chronic autoimmune inflammatory disease. Lupus nephritis (LN) is a major risk factor for mortality in SLE, and…”
    Get full text
    Journal Article
  12. 12
  13. 13